We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLG.WS
6626
DELISTED
Allego N.V. Warrants
ALLG.WS
$0 ﹤0.01%
121
FSNB
6627
DELISTED
Fusion Acquisition Corp. II
FSNB
-116
Closed -$1K
CCV
6628
DELISTED
Churchill Capital Corp V
CCV
-795
Closed -$8K
MKUL
6629
DELISTED
Molekule Group, Inc. Common Stock
MKUL
-20
Closed
GFOR.U
6630
DELISTED
Graf Acquisition Corp. IV Units, each consisting of one share of common stock, and one-fifth of one redeemable warrant
GFOR.U
-100
Closed -$1K
UPTDU
6631
DELISTED
TradeUP Acquisition Corp. Unit
UPTDU
-24
Closed
MCLD
6632
DELISTED
mCloud Technologies Corp. Common Shares
MCLD
$0 ﹤0.01%
100
-100
-50% -$106
SLVR
6633
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
-3
Closed
OTMOW
6634
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
$0 ﹤0.01%
35
LMNL
6635
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$0 ﹤0.01%
40
FATH.WS
6636
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$0 ﹤0.01%
100
BRDS.WS
6637
DELISTED
Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share
BRDS.WS
$0 ﹤0.01%
100
PRTK
6638
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-3,768
Closed -$10K
ZEV.WS
6639
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$0 ﹤0.01%
109
TKAT
6640
DELISTED
Takung Art Co., Ltd.
TKAT
$0 ﹤0.01%
462
+192
+71% +$146
NSTD
6641
DELISTED
Northern Star Investment Corp. IV
NSTD
-24
Closed
NSTD.U
6642
DELISTED
Northern Star Investment Corp. IV Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTD.U
$0 ﹤0.01%
7
ROIVW
6643
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$0 ﹤0.01%
126
CCAIU
6644
DELISTED
Cascadia Acquisition Corp. Unit
CCAIU
-400
Closed -$4K
CCAI
6645
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
$0 ﹤0.01%
16
-1
-6% -$10
SABRP
6646
DELISTED
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
-1
Closed
FXCOW
6647
DELISTED
Financial Strategies Acquisition Corp. Warrants
FXCOW
$0 ﹤0.01%
100
GFX.U
6648
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
$0 ﹤0.01%
1
APGNW
6649
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$0 ﹤0.01%
58
UBP
6650
DELISTED
Urstadt Biddle Properties Inc.
UBP
$0 ﹤0.01%
+18
New +$335

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.